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Abstract 
 
Background: Patients sensitized to birch pollen frequently suffer from a food allergy to 
plant foods such as celery, carrots, or hazelnut. One of the main manifestations of birch 
pollen-related food allergy is the oral allergy syndrome. Skin tests and allergen-specific 
immunoglobulin (Ig) E determinations are poor predictors of such reactions when 
assessed by double blind placebo-controlled food challenge (DBPCFC). 
Objective: To investigate whether a cellular test based on leukotriene release from 
basophils, the cellular antigen stimulation test in combination with enzyme-linked 
immunosorbent assay (CAST-ELISA), is predictive of pollen-related food allergy. 
Methods: Birch pollen-sensitized patients with positive DBPCFC to celery (n=21), hazelnut 
(n=15), and carrot (n=7) underwent skin tests, specific IgE determinations, and CAST-
ELISA to the respective allergens. The results were compared with those of 24 birch 
pollen-sensitized patients with negative open food challenge to celery, hazelnut, and 
carrot. 
Results: While skin prick tests had a sensitivity of 85%, 80%, and 29% for commercial 
extracts of celery, hazelnut, and carrot, respectively, prick testing with self-prepared 
extracts yielded sensitivities of 100%, 80%, and 100%, respectively. For specific IgE 
determinations, sensitivities were 71%, 73%, and 57%, respectively, and the respective 
specificities were 67%, 73%, and 60%. For CAST-ELISA with various sources and doses 
of allergens, the sensitivity varied from 71% to 95% for celery, 73% to 80% for hazelnut, 
and 43% to 86% for carrot. The respective specificities were 67% to 92%, 75% to 88%, 
and 77% to 91%. Analysis of the predictive value of CAST-ELISA with receiver operating 
characteristic curves showed that the results of the tests were more predictive of pollen-
related food allergy than quantitative allergen-specific IgE determinations. 
Conclusions: CAST-ELISA is more specific for the diagnosis of pollen-related food allergy 
to celery, hazelnut and carrot than routine diagnostic tests.   
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Introduction 
 
Allergy to foods affects about 3% to 4% of the adult population [1]. One of its most 
frequent manifestations is the oral allergy syndrome (OAS), characterized by oral and 
pharyngeal mucosal symptoms following the ingestion of allergenic foods [2,3]. In 
particular, patients sensitized to birch pollen may develop oral symptoms after ingestion of 
apples, pears, hazelnuts, kiwi, carrots, celery, and many others [4,5].  
Diagnosis of food allergy is based first on the patient’s history, followed by skin prick 
tests (SPT) and analysis of food-specific immunoglobulin (Ig) E. Some of these tests have 
a relatively high sensitivity but they do not distinguish between pure sensitization and 
clinically relevant allergy. Thus, many test-positive patients tolerate the corresponding food 
without problems [6]. For that reason, the gold standard in food allergy continues to be 
double-blind placebo-controlled food challenge (DBPCFC) [7]. Unfortunately, DBPCFC is a 
tedious and time-consuming procedure that is not without risk for the patient. 
Consequently, there is a consensus that any in vitro diagnostic test that could replace or 
reduce the need for DBPCFC would be of considerable benefit in the diagnosis of food 
allergy. Cellular tests represent candidates to replace DBPCFC, since the stimulation of 
IgE-loaded basophils in vitro is, in principle, more representative of the pathophysiologic 
process occurring in vivo than simple determination of serum IgE concentrations. Since 
1993, a new sulfidoleukotriene-release test, the cellular antigen stimulation test (CAST) in 
combination with enzyme-linked immunosorbent assay (ELISA), known as CAST-ELISA 
has been shown to be of interest in the diagnosis of IgE-mediated allergies to inhalant 
allergens, insect venoms, latex, and some drugs [8]. It has also been shown to display 
high sensitivity and specificity in IgE-mediated allergies to a number of allergenic foods 
[9,10]. 
 The aim of this study was to investigate whether CAST-ELISA is useful in diagnosis 
of allergy to hazelnut, celery, or carrot in patients sensitized to birch pollen with or without 
OAS to these food allergens. In particular, we sought to establish whether CAST-ELISA 
exhibited predictive value and whether the results of the test were correlated with those of 
DBPCFC in such patients. 
 
 
Materials and Methods 
 
Patients 
The study included 64 patients aged 16 to 62 years (23 male and 41 female) who 
were sensitized to birch pollen. All of them had positive SPT results to birch pollen extract 
and 96.4% also a positive specific IgE test to t3 (birch) allergen, as measured by 
fluorescent enzyme immunoassay (CAP-FEIA). Twenty-one patients had a positive 
DBPCFC to celery, 15 to hazelnut, and 7 to carrot. In comparison, 24 birch-sensitized 
patients had a negative open food challenge to celery, 16 to hazelnut, and 21 to carrots.  
 
Ethical Considerations 
 The study was reviewed and approved by the Local Ethics Committee of the 
University of Zurich. All subjects provided signed informed consent before enrollment in 
the study.  
 
Food Challenges 
Food challenges were performed and evaluated as described by Ballmer-Weber et al. 
[4,5,11]. Birch pollen-allergic patients without a history of a pollen-related food allergy 
underwent open food challenges to confirm clinical tolerance. To exclude food allergy, 
those patients ingested 20 g of raw carrots, 20 g of raw celery, and 6 g of raw hazelnuts, 
respectively. 
 
Skin Testing 
 SPT was performed with commercial extracts of birch pollen (Soluprick, ALK, 
Horsholm, Denmark), celery (Allergopharma, Reinbek, Germany), hazelnut, and carrot 
(Stallergènes, Antony Cedex, France) on the flexor aspect of each patient’s forearm with a 
standardized prick needle (Stallerpoint, Stallergènes). Histamine dihydrochloride (10 
mg/mL) was used as a positive control, and the glycerol-containing diluent of the prick 
solution (Soluprick, ALK-Abéllo, Horsholm, Denmark) was used as a negative control. 
Patients also underwent skin testing with self-prepared food extracts, as described 
previously [4,5,11,12]. Reactions were recorded after 15 minutes. Wheals greater than 3 
mm in diameter were considered positive. Skin tests were only done with the suspected 
culprit food allergen in DBPCFC-positive patients.  
 
In Vitro Testing 
 Analysis of allergen-specific IgE to birch, celery, hazelnut, and carrots was 
performed by CAP-FEIA (Phadia, Uppsala, Sweden) according to the manufacturer’s 
instructions. IgE concentrations above 0.35 kIU/L were considered positive. 
 CAST-ELISA consists of an initial step involving in vitro incubation of isolated blood 
leukocytes with the putative allergen, in the presence of a low concentration of interleukin 
3, for 40 minutes. Then, the concentration of sulfidoleukotrienes (leukotrienes C4, D4, and 
E4) released are analyzed by ELISA with a highly specific monoclonal antibody [8]. The 
results are evaluated in terms of the concentration of sulfidoleukotrienes (pg/mL). The test 
was performed according to the manufacturer’s instructions (Bühlmann Laboratories AG, 
Allschwil, Switzerland) and further details are described elsewhere [8]. The celery, 
hazelnut, and carrot allergens used for CAST-ELISA were provided by Bühlmann 
Laboratories and used at final concentrations of 0.8, 4, and 20 ng/mL, respectively. The 
self-prepared extracts were used at final concentrations of 4, 20, and 100 ng/mL, 
respectively. To determine the diagnostic sensitivity and specificity of CAST-ELISA with 
the corresponding food allergens, 20 apparently healthy randomly selected blood donors 
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with no history of allergy were included. CAST-ELISA reactions to birch pollen allergens 
were analyzed in 7 patients only. All 7 subjects showed specific stimulations of at least 
1615 pg/mL sulfidoleukotrienes. 
  
Statistical Analysis 
 Thresholds for optimal sensitivity and specificity of CAST-ELISA were established 
using receiver operating characteristic (ROC) curves according to Zweig and Campbell 
[13]. Sensitivity, specificity, positive predictive value, and negative predictive value were 
calculated according to the method of Goldman [14]. The Mann-Whitney test [15] was 
used to compare CAST-ELISA results between healthy controls, birch pollen-allergic 
patients without OAS, and DBPCFC-positive patients. A P value of less than .05 was 
regarded as statistically significant. 
 
Results 
 
 ROC plots were prepared to determine the cutoff for positivity in CAST-ELISA to 
achieve optimal sensitivity and specificity in patients with a positive DBPCFC. The results 
for the different allergen preparations and concentrations are summarized in Table 1. The 
sensitivities obtained with 0.8 and 4 ng/mL final allergen concentration were too low, and 
therefore, these data were not considered further. For allergen concentrations between 20 
and 100 ng/mL, the optimal cutoff ranged between 50 and 200 pg/mL sulfidoleukotrienes. 
For the sake of simplicity and direct comparison of individual results, a single cutoff of 120 
pg/mL sulfidoleukotrienes was chosen.  
 The results of comparisons between birch pollen-sensitized patients with either a 
positive DBPCFC or a negative open food challenge to the ingestion of celery, hazel, or 
carrot are shown in Table 2. In general, the results obtained with CAST-ELISA using a 
concentration of 100 ng/mL were less specific (more DBPCFC-negative patients who were 
CAST-ELISA positive).  
With 20 ng/mL of the self-prepared extracts, CAST-ELISA for celery was positive in 
85.7% of the DBPCFC-positive patients but only in 8.3% of the challenge-negative 
subjects. This contrasts with the results of the specific IgE determination, since 33.3% of 
the challenge-negative subjects were positive. For skin tests, the respective sensitivities 
were 85% (SPT with commercial extracts) and 100% (SPT with self-prepared extracts). As 
skin-test data were only available for DBPCFC-positive patients, specificities for SPT were 
not assessed. 
CAST-ELISA using 20 ng/mL of commercial allergen extract for hazelnut was 
positive in 73.3% of DBPCFC-positive patients and 12.5% of challenge-negative subjects. 
Analysis of specific IgE was positive in 73.3% and 27.3% of subjects, respectively. A 
somewhat higher sensitivity of 80% was obtained with skin tests independent of the 
allergenic extract used.  
For carrot, positive CAST-ELISA results were obtained in 85.7% of the DBPCFC-
positive patients and in 9.1% of the challenge-negative patients. Analysis of specific IgE 
was positive in 57.1% and 40%, respectively. SPT with the self-prepared extracts gave a 
sensitivity of 100%, whereas SPT with the commercial extract showed only 28.6% 
positivity, suggesting that the commercial carrot extract was not very effective. 
For all three food allergens, the positive predictive values and negative predictive 
values appeared higher for CAST-ELISA than for specific IgE determinations (Table 2). 
 When tested in normal healthy controls, CAST-ELISA showed 95% to 100% 
specificity for all 3 food allergens up to a final concentration of 100 ng/mL, independently 
of the allergen source. However, there were significant differences between allergen 
sources and concentrations to be used in CAST-ELISA when tested in symptomatic 
patients (Table 2). The same phenomenon was also observed for the skin tests. The most 
appropriate allergens to be applied for CAST-ELISA seemed to be the commercial ones 
(except celery) at a final concentration of 20 ng/mL. The discriminative power of CAST-
ELISA under those conditions is shown in Figure 1, where single CAST-ELISA results are 
shown for healthy controls stimulated with each of the 3 food allergens, challenge-negative 
patients, most of them stimulated with each of the 3 food allergens, and DBPCFC-positive 
patients stimulated with the culprit food allergen. The mean net stimulation was 15 pg/mL 
sulfidoleukotrienes for control subjects, 131 pg/mL for challenge-negative patients, and 
1078 pg/mL for DBPCFC-positive patients. Significant differences were observed between 
the groups (P < .001). 
 The capacity of CAST-ELISA to discriminate between DBPCFC-positive and 
challenge-negative patients is shown in Figure 2 for the individual food allergens at 20 
ng/mL and in Figure 3, where all DBPCFC challenges are considered together and 
compared to the alternative test methods. 
 Considering all tested individuals case by case ,SPT and analysis of specific IgE 
were frequently positive in patients without OAS, whereas CAST-ELISA seemed to 
coincide with clinical reactivity in most cases. 
 It was recently claimed that quantitative determination of specific IgE has some 
predictive value in terms of the outcome of DBPCFC [16,17]. The correlation between the 
results of analysis of specific IgE and DBPCFC to birch and foods (celery, hazelnut and 
carrot) in our cases is shown in Figure 4. Although a weak correlation was observed for 
the food allergens, it was clearly weaker than the correlations observed for the qualitative 
(positive/negative CAST-ELISA) or quantitative measures of CAST-ELISA with DBPCFC. 
 
Discussion 
 
Since its introduction around 1993, CAST-ELISA has been used relatively 
infrequently in food allergy [8-10,18-19], despite its sensitivity (81%-85%) and specificity 
(95%-100%) having been reported to be quite high, often higher than that of SPT and/or 
analysis of specific IgE [9-10,18-19] Specificities, however, have mostly been determined 
against a panel of healthy controls, and both clinically validated studies [9,18] have not 
addressed whether CAST-ELISA discriminates between immunologically sensitized 
patients—based on SPT results or analysis of specific IgE—who have a positive result in 
food challenge and those in whom food challenge is negative.  
The results of this study show that, in the majority of cases, CAST-ELISA with 
celery, hazelnut, and carrot allergens discriminates between birch pollen-sensitized 
patients who show positive or negative results in challenges with these allergenic foods. 
The greatest discriminatory power lies within a limited range of allergen concentrations. If 
the concentration is too low (less than 20 ng/mL) the test is not sufficiently sensitive, 
whereas if the concentration is too high (greater than 100 ng/m), a positive result may be 
obtained in some birch-sensitized patients in whom the results of food challenge are 
negative, even though the results of CAST-ELISA are still negative in healthy 
nonsensitized controls. Accordingly, the optimal allergen concentration to discriminate 
prospectively between challenge-positive and challenge-negative patients appears to be 
around 20 ng/mL of total protein for celery, hazelnut and carrot, and this concentration 
may also be valid for other allergenic foods. Apart from the optimal allergen concentration, 
the quality of the allergen extract seems to be crucial and has to be thoroughly controlled 
for each new batch, as is also true of the commercial CAST allergens. It is apparent, 
however, that once the appropriate allergen concentration has been determined, CAST-
ELISA correlates better with clinical reactivity than SPT or determination of specific IgE 
concentration . 
All currently used test methods are influenced by the phenomenon of immunological 
cross-reactivity between birch pollen allergens and the related food allergens, and as a 
result, patients with a positive SPT to the cross-reactive foods may not be clinically allergic 
to those foods. Thus, it is not surprising that a test based on basophil reactivity might 
correlate better with clinical reactivity than does determination of IgE concentrations. In 
addition to the presence of IgE antibodies, this test also takes into account the individual 
cellular reactivity of each patient [8]. Recently, it has been shown in a similar situation of 
birch pollen-sensitized patients with plant-related allergy that the flow cytometric basophil 
activation test can discriminate between patients with and without food allergy [20,21], with 
a sensitivity of 88% and a specificity of 75% [21]. 
 Further confirmation of the discriminatory power of CAST-ELISA should be obtained 
through multicenter studies including additional allergenic foods and more severe 
manifestations of IgE-mediated allergy, such as generalized urticaria, respiratory 
symptoms, gastrointestinal symptoms, or even anaphylactic reactions. SPT and specific 
IgE determinations may continue to be first-line diagnostic tools in food allergy, and 
DBPCFC the gold standard, but CAST-ELISA offers significant advantages as a 
complementary test that will remove the need for DBPCFC, at least in part, in the routine 
management of food-allergic patients. 
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Legends 
 
 
Figure 1. Results of the cellular antigen stimulation test in combination with enzyme-linked 
immunosorbent assay (CAST-ELISA) in healthy controls (HC), birch pollen-allergic patients 
without oral allergy syndrome (t3+/OAS-) and birch pollen-allergic patients with a positive 
response to double-blind placebo-controlled food challenge (OAS+). Horizontal bars 
indicate mean values. 
 
Figure 2. Sensitivity and specificity of the cellular antigen stimulation test in combination 
with enzyme-linked immunosorbent assay (CAST-ELISA) for the individual food allergens 
using double-blind placebo-controlled food challenge (DBPCFC) as the gold standard. 
CAST-ELISA was performed with the commercial allergens f17 (hazelnut) and f31 (carrot) 
and with a self-prepared extract of raw celery (f85), all at a concentration of 20 ng/mL. 
Open columns indicate DBPCFC-positive patients (sensitivity); closed columns, birch 
pollen-allergic patients without oral allergy syndrome (specificity).  
 
Figure 3. Overall sensitivity and specificity (celery, hazelnut, and carrot) of the cellular 
antigen stimulation test in combination with enzyme-linked immunosorbent assay (CAST-
ELISA), analysis of specific immunoglobulin E by fluorescent enzyme immunoassay (CAP-
FEIA) and skin prick tests (SPT) with commercial (SPT-1) and self-prepared (SPT-2) 
extracts using double-blind placebo-controlled food challenge (DBPCFC) as the gold 
standard. OAS+ indicates patients with oral allergy syndrome, determined by DBPCFC; 
t3+/OAS-, birch pollen-allergic patients without OAS; BL-20, commercial allergens 
(Bühlmann) at final concentrations of 20 ng/mL; PEI-100, allergen extracts prepared by the 
Paul Ehrlich Institute at final concentrations of 100 ng/mL. 
 
Figure 4. Correlation between the percentage of patients with a positive double-blind 
placebo-controlled food challenge (DBPCFC) and the results of the cellular antigen 
stimulation test in combination with enzyme-linked immunosorbent assay (CAST-ELISA) 
and fluorescent enzyme immunoassay (CAP-FEIA).. 
Table 1. Overall Diagnostic Sensitivity of the Cellular Antigen Stimulation Test with 
Enzyme-Linked Immunosorbent Assay (CAST-ELISA) According to Cutoff and Allergen 
Sourcea  
 
Sensitivity, % 
Allergen  
Source 
Allergen 
Concentration
Cutoff, pg /mL 
Sulfidoleukotrienes
OAS+ Healthy Controls 
Bühlmann 20 ng/mL 50 83.7 93.3 
(commercial)  100 74.4 96.7 
   120 74.4 98.3 
   150 72.1 100 
   200 69.8 100 
Self-prepared 20 ng/mL 50 79.1 98.3 
extracts  100 74.4 100 
   120 72.1 100 
   150 69.8 100 
   200 65.1 100 
Self-prepared 100 ng/mL 50 95.3 85.0 
extracts  100 90.7 93.3 
   120 88.4 96.7 
   150 86.0 98.3 
   200 86.0 100 
Abbreviations: OAS, oral allergy syndrome. 
aThe sensitivity of the cellular antigen stimulation test with enzyme-linked immunosorbent 
assay was assessed in 20 healthy controls with different sources and concentrations of 
celery, carrot, and hazelnut extracts, whereas 39 patients with oral allergy syndrome shown 
by positive double-blind placebo-controlled food challenge were tested with the extract of 
the culprit foods alone. The data for the 3 different food allergen were taken together and 
the respective sensitivities and specificities were calculated using various cutoff thresholds. Kommentar [IKP5]: Author: 
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Table 2. Sensitivity, Specificity, and Positive and Negative Predictive Value for the Different 
Diagnostic Testsa 
 
 
DBPCFC Test
Allergen 
Source
Allergen 
Concentration
Sensitivity, 
%
Specificity, 
% PPV, % NPV, %
Celery CAST-ELISA Commercial 20 ng/mL 71.4 91.7 88.2 78.6
21 positive Self-prepared 20 ng/mL 85.7 91.7 90.0 88.0
24 negative Self-prepared 100 ng/mL 95.2 66.7 71.4 94.1
CAP-FEIA 71.4 66.7 75.0 62.5
SPT-1 Allergopharma 44 µg/mL 85.0 nd na na
SPT-2 Self-prepared 1 mg/mL 100 nd na na
Hazelnut CAST-ELISA Commercial 20 ng/mL 73.3 87.5 84.6 77.8
15 positive Self-prepared 20 ng/mL 66.7 87.5 83.3 73.7
16 negative Self-prepared 100 ng/mL 80.0 75.0 75.0 80.0
CAP-FEIA 73.3 72.7 78.6 66.7
SPT-1 Stallergènes 6.26 mg/mL 80.0 nd na na
SPT-2 Self-prepared 1 mg/mL 80.0 nd na na
Carrot CAST-ELISA Commercial 20 ng/mL 85.7 90.9 75.0 95.2
7 positive Self-prepared 20 ng/mL 42.9 86.4 50.0 82.6
21 negative Self-prepared 100 ng/mL 85.7 77.3 54.5 94.4
CAP-FEIA 57.1 60.0 40.0 75.0
SPT-1 Stallergènes 28.6 nd na na
SPT-2 Self-prepared 1 mg/mL 100 nd na na   
Abbreviations: CAP-FEIA, fluorescent enzyme immunoassay; CAST-ELISA, cellular 
antigen stimulation test with enzyme-linked immunosorbent assay; DBPCFC, double-blind 
placebo-controlled food challenge; na, not analyzed; nd, not determined; NPV, negative 
predictive value; PPV, positive predictive value; SPT, skin prick test. 
aTests were performed with commercial food extracts and self-prepared food extracts in 
patients with positive and negative food challenges to hazelnut, carrot, and celery. DBPFC 
was used as the gold standard. 
Table 3. Individual results of CAST®-ELISA, specific IgE (as determined by CAP-FEIA), 
skin prick test with commercial (SPT-1) and self prepared (SPT-2) extracts in patients with 
positive and negative food challenge tests. hazelnut (ha, f17); carrot (ca, f31); celery (ce, 
f85);  OAS, oral allergy syndrome; sens, Sensitization to birch pollen (spIgE positive); SIT, 
specific immunotherapy; w/o, without; nd, not determined. 
 
SPT-1 SPT-2 SPT-1 SPT-2 SPT-1 SPT-2
Patient Clinical Status
Challenge 
positive to f17 f31 ce f17 f31 f85 ha ha ca ca ce ce
1 Birch sens. with OAS ha 945 1.29 + ++
2 Birch sens. with OAS ha 1633 <0.35 - +
3 Birch sens. with OAS ha 503 <0.35 ++ ++
4 Birch sens. with OAS ha 1393 2.88 +++ +
5 Birch sens. with OAS ha <50 2.16 ++ +
6 Birch sens. with OAS ha <50 3.44 + +
7 Birch sens. with OAS ha 1218 1.73 + +
8 Birch sens. with OAS ha <50 4.89 - +
9 Birch sens. with OAS ha 340 0.99 + -
10 Birch sens. with OAS ha 2053 <0.35 + +
11 Birch sens. with OAS ha 1449 0.80 + ++
12 Birch sens. with OAS ha 711 <0.35 + +
13 Birch sens. with OAS ca <50 10.3 +++ ++
14 Birch sens. with OAS ca 1257 <0.35 - +++
15 Birch sens. with OAS ca 277 5.13 - +++
16 Birch sens. with OAS ca 1261 <0.35 - +
17 Birch sens. with OAS ca 203 0.92 - ++
18 Birch sens. with OAS ca 159 <0.35 - +
19 Birch sens. with OAS ce 2466 <0.35 + ++
20 Birch sens. with OAS ce 449 1.21 + +
21 Birch sens. with OAS ce 1787 <0.35 ++ +++
22 Birch sens. with OAS ce 985 <0.35 ++ ++
23 Birch sens. with OAS ce 2842 <0.35 + +++
24 Birch sens. with OAS ce <50 0.36 + +
25 Birch sens. with OAS ce 1669 2.28 +++ +++
26 Birch sens. with OAS ce 846 38.3 +++ ++
27 Birch sens. with OAS ce 132 4.77 ++ +++
28 Birch sens. with OAS ce 1917 8.79 +++ +++
29 Birch sens. with OAS ce 1652 20.6 +++ ++
30 Birch sens. with OAS ce 2549 2.46 + +
31 Birch sens. with OAS ce >3200 6.3 +++ +
32 Birch sens. with OAS ce 589 0.46 - ++
33 Birch sens. with OAS ce 1444 <0.35 +++ ++
34 Birch sens. with OAS ce <50 1.06 - +
35 Birch sens. with OAS ce <50 <0.35 - +
36 Birch sens. with OAS ha,ce 3100 >3200 0.61 1.96 + - +++ +
37 Birch sens. with OAS ha,ce 3115 3073 2.78 4.55 - - +++ ++
38 Birch sens. with OAS ha,ce <50 738 0.73 2.41 + + ++ +++
39 Birch sens. with OAS ca,ce >3200 >3200 30.2 0.79 ++ +++ ++ +++
40 Birch sens. w/o OAS neg <50 <50 <50 <0.35 2.41 0.89
41 Birch sens. w/o OAS neg <50 <50 <50 <0.35 <0.35 <0.35
42 Birch sens. w/o OAS neg <50 498 1069 <0.35 0.41 <0.35
43 Birch sens. w/o OAS neg <50 <50 <50 <0.35 <0.35 <0.35
44 Birch sens. w/o OAS neg nd <50 <50 nd 1.68 1.16
45 Birch sens. w/o OAS neg nd <50 <50 nd <0.35 <0.35
46 Birch sens. w/o OAS neg <50 <50 <50 <0.35 <0.35 <0.35
47 Birch sens. w/o OAS neg 292 543 <50 0.98 <0.35 <0.35
48 Birch sens. w/o OAS neg <50 <50 137 2.11 1.05 0.65
49 Birch sens. w/o OAS neg nd nd <50 nd nd 0.78
50 Birch sens. w/o OAS neg nd <50 <50 nd <0.35 <0.35
51 Birch sens. w/o OAS neg <50 <50 <50 0.65 <0.35 <0.35
52 Birch sens. w/o OAS neg <50 <50 <50 <0.35 <0.35 <0.35
53 Birch sens. w/o OAS under SIT neg <50 <50 <50 <0.35 <0.35 <0.35
54 Birch sens. w/o OAS under SIT neg nd nd <50 nd nd nd
55 Birch sens. w/o OAS under SIT neg <50 <50 <50 nd nd nd
56 Birch sens. w/o OAS under SIT neg <50 <50 <50 nd nd nd
57 Birch sens. w/o OAS under SIT neg nd <50 <50 nd 1.10 1.51
58 Birch sens. w/o OAS under SIT neg nd <50 <50 nd nd nd
59 Birch sens. w/o OAS under SIT neg nd <50 <50 nd nd nd
60 Birch sens. w/o OAS under SIT neg <50 <50 <50 nd nd nd
61 Birch sens. w/o OAS under SIT neg <50 <50 <50 nd nd nd
62 Birch sens. w/o OAS under SIT neg nd nd <50 nd nd nd
63 Birch sens. w/o OAS under SIT neg <50 <50 nd <0.35 0.79 nd
64 Birch sens. w/o OAS under SIT neg 2448 <50 <50 nd nd nd
CAST-ELISA (pg/ml) CAP-FEIA (kIU/L)
 
 
Kommentar [IKP6]: Author: 
Provision of raw data in this way 
seems an inappropriate repetition of 
information that has already been 
provided. It should be removed, 
unless you can explain what 
relevant additional information it 
provides. Ok, Table 3 shall be 
removed! 
Figure 1 
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Kommentar [IKP7]: Author: 
Please make the following changes 
in the figure: 
1)Change "sLT release (pg/mL)" to 
"Sulfidoleukotriene Release, pg/mL 
2) Change "p<0.0001" to "P < .001" 
Done! 
Figure 2 
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Kommentar [IKP8]: Author: 
Please change "Sensitivity / 
Specificity (%)" to " 
Sensitivity/Specificity, %" Done! 
Figure 3 
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Kommentar [IKP9]: Author: 
Please make the following changes 
in the figure: 
1) Change "CAST" to "CAST-
ELISA" Done! 
Figure 4 
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Kommentar [IKP10]: Author: 
Please make the following changes 
in the figure: 
1) Change "spIgE (kIU/L)" to 
"Specific IgE, kIU/L" 
2) Change "DBPCFC positive 
patients (%)" to "DBPCFC-Positive 
Patients, %" 
3) Change "sLT release (pg/mL)" to 
"Sulfidoleukotriene Release, 
pg/mL" and change the direction of 
the text to face in to the graph 
(reading from top to bottom) Done! 
